Skip to main content
. 2024 Aug 30;12:100131. doi: 10.1016/j.obpill.2024.100131

Table 2.

Primary indication for referral to management of obesity with intensive behavioral therapy (IBT).

Covariate IP (n = 62) TM (n = 77) P-value IP with ≥2 visits (n = 45) TM with ≥2 visits (n = 62) P-value
Primary indication for referral to IBT program
Chronic back pain 2 (3.2) 0 (0) 0.826 1 (2.2) 0 (0) 0.238
Chronic cephalea 2 (3.2) 0 (0) 0.826 2 (4.4) 0 (0) 0.094
Chronic heart failure 1 (1.6) 1 (1.3) 0.877 1 (2.2) 1 (1.6) 0.818
Degenerative disc disease 1 (1.6) 5 (6.5) 0.159 1 (2.2) 5 (8.1) 0.195
Prediabetes or diabetes mellitus 7 (11.3) 9 (11.7) 0.942 4 (8.9) 9 (14.5) 0.379
GERD/HH 13 (21) 27 (35.1) 0.069 13 (28.9) 17 (27.4) 0.867
Hyperlipidemia 0 (0) 4 (5.2) 0.069 0 (0) 4 (6.5) 0.082
Hypertension 6 (9.7) 3 (3.9) 0.169 5 (11.1) 3 (4.8) 0.223
Incisional hernia 1 (1.6) 2 (2.6) 0.702 1 (2.2) 2 (3.2) 0.756
Obesity 7 (11.3) 12 (15.6) 0.463 4 (8.9) 9 (14.5) 0.379
Other conditions 5 (8) 7 (9.1) 0.830 3 (6.7) 6 (9.7) 0.579
Other endocrinological disorders 1 (1.6) 0 (0) 0.263 1 (2.2) 0 (0) 0.238
Other neurological disorders 4 (6.5) 1 (1.3) 0.105 2 (4.4) 0 (0) 0.094
Polycystic ovary syndrome 4 (6.5) 3 (3.9) 0.493 2 (4.4) 3 (4.8) 0.924
Pulmonary disease 8 (12.9) 3 (3.9) 0.051 5 (11.1) 3 (4.8) 0.223

Variables are presented as count and proportions. Bold p-values represent statistical significance at p < 0.05. Abbreviations: GERD: gastro-esophageal reflux disease; HH: hiatal hernia; IP: in-person modality group; TM: telemedicine modality group.